viewANDmorbid
Mobidity No. Mim No. Gene Number Morbiity Map Disorder Gene Disoder No. 1 Gene Disoder No. 2 Relationships
236730 236730 10.108 Urofacial syndrome (2) Urofacial syndrome (2) Urofacial syndrome (Ochoa syndrome)
138130 138130 10.115 Hyperinsulinism-hyperammonemia syndrome (3) Hyperinsulinism-hyperammonemia syndrome (3) Glutamate dehydrogenase-1 pseudogene on Xq26-q28
601728 601728 10.119 Endometrial carcinoma (3) Cowden disease 158350 (3); Lhermitte-Duclos syndrome (3); Phosphatase and tensin homolog (mutated in multiple advanced cancers
601728 601728 10.119 Cowden disease- 158350 (3) Cowden disease 158350 (3); Lhermitte-Duclos syndrome (3); Phosphatase and tensin homolog (mutated in multiple advanced cancers
601728 601728 10.119 Lhermitte-Duclos syndrome (3) Cowden disease 158350 (3); Lhermitte-Duclos syndrome (3); Phosphatase and tensin homolog (mutated in multiple advanced cancers
601728 601728 10.119 Bannayan-Zonana syndrome- 153480 (3) Cowden disease 158350 (3); Lhermitte-Duclos syndrome (3); Phosphatase and tensin homolog (mutated in multiple advanced cancers
600512 600512 10.121 Epilepsy- partial (2) Epilepsy partial (2) Epilepsy partial
157640 157640 10.124 PEO with mitochondrial DNA deletions- type 1 (2) PEO with mitochondrial DNA deletions type 1 (2) Progressive external ophthalmoplegia type 1
601107 601107 10.125 Dubin-Johnson syndrome- 237500 (3) Dubin-Johnson syndrome 237500 (3) ATP-binding cassette subfamily C member 2
602082 602082 10.127 Corneal dystrophy- Thiel-Behnke type (2) Corneal dystrophy Thiel-Behnke type (2) Corneal dystrophy Thiel-Behnke type
601130 601130 10.129 Tolbutamide poor metabolizer (3) Tolbutamide poor metabolizer (3); Warfarin sensitivity 122700 (3) Cytochrome P450 subfamily IIC (mephenytoin 4-hydroxylase)
186770 186770 10.132 Leukemia- T-cell acute lymphocytic (2) Leukemia T-cell acute lymphocytic (2) Homeo box-11 (T-cell leukemia-3 associated breakpoint homologous to t(7;10) or t(10;4)
271245 271245 10.134 Spinocerebellar ataxia-8- infantile- with sensory neuropathy (2) Spinocerebellar ataxia infantile-onset with sensory neuropathy (2) Infantile-onset spinocerebellar ataxia
180250 180250 10.141 Retinol binding protein- deficiency of (1) (?) Retinol binding protein deficiency of (3) Retinol-binding protein-4 interstitial just centromeric of CYP2C cluster
600095 600095 10.142 Split hand/foot malformation- type 3 (2) Split hand/foot malformation type 3 (2) Split hand/foot malformation type 3 (dactylin)
278000 278000 10.146 Cholesteryl ester storage disease (3) Wolman disease (3); Cholesteryl ester storage disease (3) Lipase A lysosomal acid cholesterol esterase ?close to GOT
278000 278000 10.146 Wolman disease (3) Wolman disease (3); Cholesteryl ester storage disease (3) Lipase A lysosomal acid cholesterol esterase ?close to GOT
134637 134637 10.156 {Autoimmune lymphoproliferative syndrome} (3) {Autoimmune lymphoproliferative syndrome} (3) Tumor necrosis factor receptor superfamily member 6
124020 124020 10.158 Mephenytoin poor metabolizer (3) Mephenytoin poor metabolizer (3) Cytochrome P450 subfamily IIC (mephenytoin 4'-hydroxylase) 4 genes in order: cen-C18-C19-C9-C8-tel
113811 113811 10.162 Epidermolysis bullosa- generalized atrophic benign- 226650 (3) Epidermolysis bullosa generalized atrophic benign 226650 (3) Collagen XVII alpha-1 polypeptide
202110 202110 10.163 Adrenal hyperplasia- congenital- due to 17-alpha-hydroxylase deficiency (3) Adrenal hyperplasia congenital due to 17-alpha-hydroxylase Cytochrome P450 subfamily XVII (steroid 17-alpha-hydroxylase) at least 2 genes; distal to GOT1
138250 138250 10.164 P5CS deficiency (1) (?) ?P5CS deficiency (1) Pyrroline-5-carboxlate synthetase GOT1 and GSAS in same pathway
167409 167409 10.165 Optic nerve coloboma with renal disease- 120330 (3) Optic nerve coloboma with renal disease 120330 (3) Paired box homeotic gene-2
600020 600020 10.17 Prostate cancer- 176807 (3) Prostate cancer 176807 (3); Neurofibrosarcoma (3) MAX-interacting protein 1
602669 602669 10.171 Cataract- congenital (3) Anterior segment mesenchymal dysgenesis and cataract 107250 (3); Paired-like homeodomain transcription factor-3
602669 602669 10.171 Anterior segment mesenchymal dysgenesis and cataract- 107250 (3) Anterior segment mesenchymal dysgenesis and cataract 107250 (3); Paired-like homeodomain transcription factor-3
263700 263700 10.179 Porphyria- congenital erythropoietic (3) Porphyria congenital erythropoietic (3) Uroporphyrinogen III synthase
147730 147730 10.18 Interleukin-2 receptor- alpha chain- deficiency of (3) Interleukin-2 receptor alpha chain deficiency of (3) Interleukin-2 receptor
601969 601969 10.182 Glioblastoma multiforme- 137800 (3) Glioblastoma multiforme 137800 (3); Medulloblastoma 155255 (3) Deleted in malignant brain tumors 1
601969 601969 10.182 Medulloblastoma- 155255 (3) Glioblastoma multiforme 137800 (3); Medulloblastoma 155255 (3) Deleted in malignant brain tumors 1
602084 602084 10.185 Endometrial carcinoma (2) Endometrial carcinoma (2) Deleted in endometrial carcinoma
176943 176943 10.187 Pfeiffer syndrome- 101600 (3) Crouzon syndrome 123500 (3); Jackson-Weiss syndrome 123150 (3); Fibroblast growth factor receptor-2 (bacteria-expressed kinase)
176943 176943 10.187 Jackson-Weiss syndrome- 123150 (3) Crouzon syndrome 123500 (3); Jackson-Weiss syndrome 123150 (3); Fibroblast growth factor receptor-2 (bacteria-expressed kinase)
176943 176943 10.187 Crouzon craniofacial dysostosis- 123500 (3) Crouzon syndrome 123500 (3); Jackson-Weiss syndrome 123150 (3); Fibroblast growth factor receptor-2 (bacteria-expressed kinase)
176943 176943 10.187 Beare-Stevenson cutis gyrata syndrome- 123790 (3) Crouzon syndrome 123500 (3); Jackson-Weiss syndrome 123150 (3); Fibroblast growth factor receptor-2 (bacteria-expressed kinase)
176943 176943 10.187 Apert syndrome- 101200 (3) Crouzon syndrome 123500 (3); Jackson-Weiss syndrome 123150 (3); Fibroblast growth factor receptor-2 (bacteria-expressed kinase)
258870 258870 10.19 Gyrate atrophy of choroid and retina with ornithinemia- B6 responsive or unresponsive (3) Gyrate atrophy of choroid and retina with ornithinemia B6 Ornithine aminotransferase pseudogene at Xp11.2
600035 600035 10.194 Schizencephaly (3) Schizencephaly (3) Empty spiracles Drosophila homolog of 2 close to VAX1
246600 246600 10.195 Pancreatic lipase deficiency (1) Pancreatic lipase deficiency (1) Pancreatic lipase
601362 601362 10.2 DiGeorge syndrome/velocardiofacial syndrome complex-2 (2) DiGeorge syndrome/velocardiofacial syndrome complex-2 (2) DiGeorge syndrome chromosome region-2
602026 602026 10.2 Refsum disease- 266500 (3) Refsum disease 266500 (3) Phytanoyl-CoA hydroxylase
602083 602083 10.22 Usher syndrome- type IF (2) Usher syndrome type IF (2) Usher syndrome-1F autosomal recessive severe
600964 600964 10.3 Refsum disease- adult- with increased pipecolicacidemia (2) Refsum disease adult with increased pipecolicacidemia (2) Refsum disease adult with increased pipecolicacidemia ?relation to PHYH
601942 601942 10.4 Insulin-dependent diabetes mellitus-10 (2) {Diabetes mellitus insulin-dependent 10} (2) Insulin-dependent diabetes mellitus-10
601188 601188 10.4 Prostate adenocarcinoma (2) Prostate adenocarcinoma (2) Suppression of tumorigenicity 12 prostate
602450 602450 10.42 Severe combined immunodeficiency disease- Athabascan type (2) Severe combined immunodeficiency disease Athabascan type (2) Severe combined immunodeficiency disease Athabascan type
601067 601067 10.44 Usher syndrome- type 1D (2) Usher syndrome type 1D (2) Usher syndrome-1D autosomal recessive severe between D10S529 and D10S573
133540 133540 10.45 Cockayne syndrome-2- late onset (2) Cockayne syndrome-2 type B (3); Cerebrooculofacioskeletal syndrome Excision repair cross complementing rodent repair deficiency
600835 600835 10.48 {AIDS- resistance to} (3) {AIDS resistance to} (3) Stromal cell-derived factor 1
164761 164761 10.56 Hirschsprung disease- 142623 (3) Multiple endocrine neoplasia IIA 171400 (3); Medullary thyroid RET transforming sequence; oncogene RET
164761 164761 10.56 Medullary thyroid carcinoma- 155240 (3) Multiple endocrine neoplasia IIA 171400 (3); Medullary thyroid RET transforming sequence; oncogene RET
164761 164761 10.56 Multiple endocrine neoplasia IIA- 171400 (3) Multiple endocrine neoplasia IIA 171400 (3); Medullary thyroid RET transforming sequence; oncogene RET
164761 164761 10.56 Multiple endocrine neoplasia IIB- 162300 (3) Multiple endocrine neoplasia IIA 171400 (3); Medullary thyroid RET transforming sequence; oncogene RET
154545 154545 10.61 {Chronic infections- due to opsonin defect} (3) {Chronic infections due to opsonin defect} (3) Mannose-binding lectin 2 soluble (opsonic defect) near MEN2A
601386 601386 10.7 Deafness- autosomal recessive 12 (2) Deafness autosomal recessive 12 (2) Deafness autosomal recessive 12
601493 601493 10.73 Cardiomyopathy- dilated 1C (2) Cardiomyopathy dilated 1C (2) Cardiomyopathy dilated-1C autosomal dominant
129010 129010 10.77 Neuropathy- congenital hypomyelinating- 1 (3) Neuropathy congenital hypomyelinating 1 605253 (3) KROX-20 Drosophila homolog of (early growth response-2)
142600 142600 10.84 Hemolytic anemia due to hexokinase deficiency (3) Hemolytic anemia due to hexokinase deficiency (3) Hexokinase-1 10p11.2 conflicting assignment; ?2 loci on chr.10
250850 250850 10.86 Hypermethioninemia- persistent- autosomal dominant- due to methionine adenosyltransferase I/III deficiency (3) Hypermethioninemia persistent autosomal dominant due to Methionine adenosyltransferase I alpha
126090 126090 10.88 Hyperphenylalaninemia due to pterin-4a-carbinolamine dehydratase deficiency- 264070 (3) Hyperphenylalaninemia due to pterin-4a-carbinolamine dehydratase Pterin-4a-carbinolamine dehydratase (dimerization cofactor of hepatic
176801 176801 10.96 Metachromatic leukodystrophy due to deficiency of SAP-1 (3) Metachromatic leukodystrophy due to deficiency of SAP-1 (3); Prosaposin (sphingolipid activator protein-1)
176801 176801 10.96 Gaucher disease- variant form (3) Metachromatic leukodystrophy due to deficiency of SAP-1 (3); Prosaposin (sphingolipid activator protein-1)